サイトロゴ

固形がんに対するアンチセンス核酸治療

This page is currently available only in English.

Advantages

Current Stage and Key Data

Partnering Model

Background and Technology

Principal Investigator

Patents and Publications

Patents and Publications

Patents

  1. GREB1 Project:
  • PCT/JP2020/020274
  • Japan (pend.) pub. # JPWO2020/235671(A1)
  • U.S. (Granted) pub. # US2022/0249538(A1)
  1. Arl4c Project:
  • PCT/JP2019/034746
  • EPO (pend.) pub. # EP3848460(A4)
  • Japan (Issued) pub. # JP7396577(B2)
  • U.S. (Issued) pub. # US12,071,624(B1)

Publications

  1. GREB1 Project:
  • Matsumoto S, et al., Nat Commun. (2019) 10(1):3882.
  • Matsumoto S, et al., Cancer Res. (2023) 83(14):2312-2327. # hepatocellular carcinoma
  • Shinzawa K, et al., Oncogene. (2023) 42(42):3142-3156. # melanoma
  1. Alr4c Project:
  • Matsumoto S, et al., EMBO J. (2014) 33(7):702-718.
  • Fujii S, et al., Oncogene (2015) 34, 4834-4844.
  • Matsumoto S, et al., J Biochem. (2017) 161(1):27-35.
  • Harada T, et al., Mol Cancer Ther. (2019) 18(3):602-612. # liver tumor
  • Kimura K, et al., Cancer Sci. (2020) 111(3):951-961. # lung adenocarcinoma
  • Harada A, et al., eLife (2021) 10:e66721. # pancreatic cancer

プロジェクト番号:jt-01804